written by reader Dave Lashmet’s new teaser stock for Obesity

By ldevitt, August 27, 2020

Any thoughts on Lashmet’s new teaser, a small biotech, under the radar with a Phase 3 completion within days or weeks? Also has a fast track pediatric designation.

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.



This site uses Akismet to reduce spam. Learn how your comment data is processed.

1 Comment
Inline Feedbacks
View all comments
👍 16195

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info